Probing the molecular mechanism of action of the HIV-1 reverse transcriptase inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) using pre-steady-state kinetics-Reference-Cited by-同舟云学术

Probing the molecular mechanism of action of the HIV-1 reverse transcriptase inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) using pre-steady-state kinetics

Published:2014-06 Issue: Volume:106 Page:1-4
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Muftuoglu Yagmur,Sohl Christal D.,Mislak Andrea C.,Mitsuya Hiroaki,Sarafianos Stefan G.,Anderson Karen S.

Funder

NIH

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference24 articles.

1. Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-gamma inhibition;Apostolova;Trends Pharmacol. Sci.,2011

2. Pre-steady-state kinetic studies establish entecavir 5′-triphosphate as a substrate for HIV-1 reverse transcriptase;Domaoal;J. Biol. Chem.,2008

3. Mechanistic studies comparing the incorporation of (+) and (−) isomers of 3TCTP by HIV-1 reverse transcriptase;Feng;Biochemistry,1999

4. KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis;Harris;Antiviral Res.,2005

5. Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract;Iyidogan;Antiviral Res.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir;Antimicrobial Agents and Chemotherapy;2024-07-09

2. Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs);Antimicrobial Agents and Chemotherapy;2022-06-21

3. Comparison of the Old and New - Novel Mechanisms of Action for Anti-coronavirus Nucleoside Analogues;CHIMIA;2022-05-25

4. Development of Human Immunodeficiency Virus Type 1 Resistance to 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains;Antimicrobial Agents and Chemotherapy;2021-11-17

5. HIV Reverse Transcriptase Pre-Steady-State Kinetic Analysis of Chain Terminators and Translocation Inhibitors Reveals Interactions between Magnesium and Nucleotide 3′-OH;ACS Omega;2021-05-25